Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cell Migration

Cell Migration

Cell migration, the process by which cells move from one location to another, is essential for the proper development and viability of organisms throughout their life. When cells are not able to migrate properly to their ordained locations, various disorders may occur. For example, disruption in cell migration causes chronic inflammatory diseases such as arthritis.

Cell Migration

Cell Migration

Cell migration is a process by which the cells move from one location to another, playing an essential role in embryological development, repair and regeneration, immune response, and metastasis. Cells migrate in response to chemical or mechanical signals generated by specific organs or tissues. The overall mechanism includes three steps - polarization, protrusion, and release. Polarization involves the formation of a distinct cell front and rear, which determines the direction of movement.

Cytoskeletal Coordination in Cell Migration

Cytoskeletal Coordination in Cell Migration

A migrating cell changes its shape during the cyclic events of attachment and detachment from the substratum and repositions the cell organelles correspondingly. These complex events are orchestrated by the dynamic cytoskeletal network comprising actin filaments, intermediate filaments, and microtubules. Cytoskeletal crosstalk — the direct and indirect communication between the different components — is crucial for this coordination. Direct communication involves various linker proteins that...

Cancer Cell Migration through Invadopodia

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...

Chemotaxis and Direction of Cell Migration

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...

Role of Myosin in Cell Migration

Role of Myosin in Cell Migration

Myosins are multimeric motor proteins involved in various cellular processes such as migration, adhesion, and proliferation. Myosin II is the most common type in animal cells, which binds and cross-links actin filaments.
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction. It is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

αKG-mediated carnitine synthesis drives DNA repair via histone acetylation.

Nature·2026

Same author

Cross-assay RNA modeling reveals cancer biomarkers.

bioRxiv : the preprint server for biology·2026

Same author

On the predictability of progression-free survival in ovarian cancer from NanoString gene expression data.

bioRxiv : the preprint server for biology·2026

Same author

Transcriptomic subtypes in high-grade serous ovarian cancer are driven by tumor cellular composition.

bioRxiv : the preprint server for biology·2026

Same author

Bayesian multi-cell type models for the analysis of complex immune cell populations with application to ovarian cancer.

Briefings in bioinformatics·2026

Same author

Chromobox 2 Inhibition: A Novel Activity of Alisertib, an Aurora A Kinase Inhibitor.

Molecular cancer therapeutics·2026

Search research articles

Related Experiment Video

Updated: May 16, 2026

Analysis of Cell Migration within a Three-dimensional Collagen Matrix

Analysis of Cell Migration within a Three-dimensional Collagen Matrix

Published on: October 5, 2014

MUC1 drives c-Met-dependent migration and scattering.

Teresa M Horm¹, Benjamin G Bitler, Derrick M Broka

¹Department of Molecular and Cellular Biology, Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA.

Molecular Cancer Research : MCR

|November 30, 2012

Summary

The MUC1 inhibitory peptide (PMIP) peptide effectively suppresses breast cancer metastasis by inhibiting cell motility. PMIP targets the metastatic mediator c-Met, offering a potential new therapeutic strategy for advanced cancers.

More Related Videos

Real-Time In Vitro Migration Assay for Primary Murine CD8+ T Cells

Real-Time In Vitro Migration Assay for Primary Murine CD8+ T Cells

Published on: May 24, 2024

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Related Experiment Videos

Last Updated: May 16, 2026

Analysis of Cell Migration within a Three-dimensional Collagen Matrix

Analysis of Cell Migration within a Three-dimensional Collagen Matrix

Published on: October 5, 2014

Real-Time In Vitro Migration Assay for Primary Murine CD8+ T Cells

Real-Time In Vitro Migration Assay for Primary Murine CD8+ T Cells

Published on: May 24, 2024

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Area of Science:

Oncology
Molecular Biology
Cancer Research

Background:

Transmembrane mucin MUC1 is overexpressed in ductal carcinomas, correlating with metastatic progression.
MUC1 interacts with oncogenic partners like EGFR and Src, driving tumor initiation and progression.
The MUC1 inhibitory peptide (PMIP) has shown promise in inhibiting MUC1's tumor-promoting activities and suppressing metastasis in preclinical models.

Purpose of the Study:

To investigate the mechanism by which PMIP inhibits breast cancer cell motility and metastasis.
To identify key molecular targets and pathways affected by PMIP treatment.
To evaluate the therapeutic potential of PMIP in blocking MUC1-driven metastatic events.

Main Methods:

Motility assays were performed to assess PMIP's effect on breast cancer cell movement.
Global gene transcription analysis was conducted to identify genes altered by PMIP treatment.
The role of c-Met in MUC1- and EGFR-mediated cell scattering, migration, and branching was evaluated.

Main Results:

PMIP treatment significantly inhibited breast cancer cell motility.
PMIP altered the expression of key genes, including the metastatic mediator c-Met.
MUC1 and EGF treatment promoted cell scattering, migration, and branching in a c-Met-dependent manner.
PMIP effectively blocked these MUC1- and EGF-driven metastatic phenotypes.

Conclusions:

PMIP inhibits breast cancer cell motility and metastasis by downregulating the expression of the metastatic mediator c-Met.
MUC1 plays a critical role in promoting cancer cell scattering, migration, and invasion, often in conjunction with EGFR signaling.
PMIP represents a promising therapeutic agent for targeting MUC1-driven metastasis in ductal carcinomas.